Ligand Pharmaceuticals Inc - Class B
NASDAQ: LGND
$116.86
+$0.31 (+0.3%)
Real Time Data Delayed 15 Min.
LGND Articles
Investors couldn’t have missed seeing the recent waves of new corporate share buyback plans. What they may have not noticed as clearly is the increasing trend in “legal insider trading” —...
Published:
These are some of this morning’s top pre-market analyst upgrades and positive research calls from Wall Street this Thursday morning with over two hours until the market opens: Axsys Technologies...
Published:
Last Updated:
This might not be the biggest of biotech mergers out there, but deals are continuing in the bio-space. Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has entered into a definitive merger...
Published:
Out of the daily movers this last week, many of the top winners and losers were from news in many of the smaller biotech stocks. We prepared a list of the winners and sinners from our daily review...
Published: